4//SEC Filing
Bardwell Kathleen 4
Accession 0001209191-19-021553
CIK 0001624899other
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 9:34 AM ET
Size
21.5 KB
Accession
0001209191-19-021553
Insider Transaction Report
Form 4
STERIS plcSTE
Bardwell Kathleen
Sr.V. P. & C.C.O.
Transactions
- Disposition to Issuer
Employee Stock Option (right to buy)
2019-03-28−10,000→ 0 totalExercise: $67.98Exp: 2025-08-10→ Ordinary Shares (10,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2019-03-28−7,000→ 0 totalExercise: $69.72Exp: 2026-06-01→ Ordinary Shares (7,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2019-03-28−7,000→ 0 totalExercise: $53.52Exp: 2024-05-30→ Ordinary Shares (7,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2019-03-28−10,000→ 0 totalExercise: $77.07Exp: 2027-05-30→ Ordinary Shares (10,000 underlying) - Disposition to Issuer
Ordinary Shares, 10 pence par value
2019-03-28−17,441→ 0 total - Disposition to Issuer
Employee Stock Option (right to buy)
2019-03-28−9,332→ 0 totalExercise: $114.22Exp: 2028-05-31→ Ordinary Shares (9,332 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2019-03-28−5,360→ 0 totalExercise: $45.34Exp: 2023-05-31→ Ordinary Shares (5,360 underlying)
Footnotes (8)
- [F1]5,072 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 625 on May 28, 2019; 500 on May 30, 2019; 393 on May 31, 2019; 500 on June 3, 2019; 375 on October 1, 2019; 500 on June 1, 2020; 500 on June 1, 2020; 393 on June 1, 2020; 500 on June 1, 2021; 393 on June 1, 2021 and 393 on May 31, 2022.
- [F2]Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.
- [F3]This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 5,360 ordinary shares of STERIS for $45.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
- [F4]This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 7,000 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
- [F5]This option becomes exercisable as follows: 2,500 on May 28, 2016; 2,500 on May 28, 2017; 2,500 on May 28, 2018; and 2,500 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 10,000 ordinary shares of STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
- [F6]This option becomes exercisable as follows: 1,750 on June 1, 2017; 1,750 on June 1, 2018; 1,750 on June 3, 2019 and 1,750 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 7,000 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
- [F7]This option becomes exercisable as follows: 2,500 on May 30, 2018; 2,500 on May 30, 2019; 2,500 on June 1, 2020 and 2,500 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 10,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option
- [F8]This option becomes exercisable as follows: 2,333 on May 31, 2019; 2,333 on June 1, 2020; 2,333 on June 1, 2021 and 2,333 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 9,332 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Documents
Issuer
STERIS plc
CIK 0001624899
Entity typeother
Related Parties
1- filerCIK 0001532367
Filing Metadata
- Form type
- 4
- Filed
- Mar 27, 8:00 PM ET
- Accepted
- Mar 28, 9:34 AM ET
- Size
- 21.5 KB